EGFR signaling through extracellular signal-regulated kinases 1/2 and casein kinase-2 in glioma cells leads to the phosphorylation of α-catenin and promotes β-catenin transactivation, which is associated with a high grade of glioma malignancy [39,40]. This evidence concerns the gene MAPK3 and glioma.